Furthermore, the irreversible peptide inhibitor RR-11a was very recently shown to be efficiently delivered intracerebrally by nanobubbles and shown to improve cognitive function and inhibit APP and Tau cleavage by legumain in an AD mouse model [131]. The gene discussed is MAPT; the disease is Alzheimer disease.